Biomaterials of Marine Origin
A section of Marine Drugs (ISSN 1660-3397).
Section Information
This Section, “Biomaterials of Marine Origin”, of Marine Drugs aims to provide a platform for the rapid publication of works concerning marine-derived biomaterials and their applications in medical or related fields.
Scope
Potential topics include, but are not limited to:
- Marine-derived biomaterials
- Marine-derived biomimetic materials
- Marine-derived biopolymers
- Marine chitin and chitosan
- Marine-derived biomaterials in drug delivery
- Marine-derived biomaterials in tissue engineering and regenerative medicine
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Novel Biomaterials and Active Compounds from Sea Cucumbers (Deadline: 30 June 2026)
- Jellyfish-Derived Compounds (Deadline: 30 June 2026)
- Marine-Derived Biomaterials for Bone Health (Deadline: 30 June 2026)
- Marine Biomaterials: Insights from Marine Invertebrates (Deadline: 31 July 2026)
- Marine-Derived Bioactives and Biomaterials for Next-Generation Cancer Therapeutics and Advanced 3D Tumor Models (Deadline: 31 July 2026)
- Marine Biopolymer with Antimicrobial and Antibiofilm Activity (Deadline: 15 August 2026)
- Marine Polysaccharides-Based Biomaterials (Deadline: 31 August 2026)
- Marine-Derived Polymers for Tissue Engineering and Drug Delivery Applications (Deadline: 31 August 2026)
- Innovative Marine Nanomaterials in Targeted Drug Delivery (Deadline: 31 August 2026)
- Marine-Derived Chitin and Chitosan: From Extraction to Applications (Deadline: 15 October 2026)
- Marine Macromolecule-Based Drug Delivery Systems: From Formulation to In Vivo Evaluation (Deadline: 31 October 2026)
- Marine-Derived Bioactive Compounds and Materials for Advanced Biomaterials Development (Deadline: 30 November 2026)
- Marine Bioactive Polymers (Deadline: 31 December 2026)
